// App-Quantinova.ai

Sa1393 : 2L Split-Dose Peg3350 Electrolyte Solution Plus Bisacodyl vs 2L Split-Dose PEG 3350 Electrolyte Solution Plus Ascorbic Acid for Outpatient Colonoscopy: Preliminary Results

Researchers

Presenter

  • Oliver Takach

Principal Investigators

  • Cherry E. Galorport

  • Andrew M. Round

  • Aaron Sobkowicz

  • Mayur Brahmania

  • Hin Hin Ko

  • Jennifer J. Telford

  • Brian Bressler

  • Robert A. Enns

Medical Centers

  • Department of Surgery, University of Toronto, Toronto, ON, Canada

  • Department of Medicine, Division of Gastroenterology, University of British Columbia, Vancouver, British Columbia, Canada

  • Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Inflammatory bowel disease

  • Constipation

Biomarkers

  • Ribosomal Protein S27a

Drug/Treatment

  • Ascorbic acid

  • Bisacodyl

  • PEG 3350

Outcome

  • N/A


Study Design

  • randomized

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final